Skip to main content
Fig. 5 | Cancer Cell International

Fig. 5

From: Expression profile analysis of antisense long non-coding RNA identifies WDFY3-AS2 as a prognostic biomarker in diffuse glioma

Fig. 5

Survival analysis in patients stratified by grade, IDH and 1p/19q status based on WDFY3-AS2 expression. ac Kaplan-Meier analysis of  WDFY3-AS2 in all grade, LGG and GBM patients. df Kaplan-Meier analysis of WDFY3-AS2 in LGG stratified by IDH and 1p/19q status. g, h Kaplan-Meier analysis of WDFY3-AS2 in GBM IDH-wt and IDH-mut patients 

Back to article page